556 related articles for article (PubMed ID: 17043671)
1. Anandamide mediates hyperdynamic circulation in cirrhotic rats via CB(1) and VR(1) receptors.
Moezi L; Gaskari SA; Liu H; Baik SK; Dehpour AR; Lee SS
Br J Pharmacol; 2006 Dec; 149(7):898-908. PubMed ID: 17043671
[TBL] [Abstract][Full Text] [Related]
2. Role of Ca2+-dependent potassium channels in in vitro anandamide-mediated mesenteric vasorelaxation in rats with biliary cirrhosis.
Yang YY; Lin HC; Huang YT; Lee TY; Hou MC; Wang YW; Lee FY; Lee SD
Liver Int; 2007 Oct; 27(8):1045-55. PubMed ID: 17845532
[TBL] [Abstract][Full Text] [Related]
3. Role of endocannabinoids in the pathogenesis of cirrhotic cardiomyopathy in bile duct-ligated rats.
Gaskari SA; Liu H; Moezi L; Li Y; Baik SK; Lee SS
Br J Pharmacol; 2005 Oct; 146(3):315-23. PubMed ID: 16025138
[TBL] [Abstract][Full Text] [Related]
4. Anandamide elicits an acute release of nitric oxide through endothelial TRPV1 receptor activation in the rat arterial mesenteric bed.
Poblete IM; Orliac ML; Briones R; Adler-Graschinsky E; Huidobro-Toro JP
J Physiol; 2005 Oct; 568(Pt 2):539-51. PubMed ID: 16081483
[TBL] [Abstract][Full Text] [Related]
5. Inhibition of hepatic tumour necrosis factor-alpha attenuates the anandamide-induced vasoconstrictive response in cirrhotic rat livers.
Yang YY; Lee KC; Huang YT; Lee FY; Chau GY; Loong CC; Lin HC; Lee SD
Liver Int; 2009 May; 29(5):678-85. PubMed ID: 19413671
[TBL] [Abstract][Full Text] [Related]
6. Mechanisms of anandamide-induced vasorelaxation in rat isolated coronary arteries.
White R; Ho WS; Bottrill FE; Ford WR; Hiley CR
Br J Pharmacol; 2001 Oct; 134(4):921-9. PubMed ID: 11606334
[TBL] [Abstract][Full Text] [Related]
7. Effect of chronic CB1 cannabinoid receptor antagonism on livers of rats with biliary cirrhosis.
Yang YY; Lin HC; Huang YT; Lee TY; Hou MC; Wang YW; Lee FY; Lee SD
Clin Sci (Lond); 2007 May; 112(10):533-42. PubMed ID: 17176248
[TBL] [Abstract][Full Text] [Related]
8. Role of the nitric oxide pathway and the endocannabinoid system in neurogenic relaxation of corpus cavernosum from biliary cirrhotic rats.
Ghasemi M; Sadeghipour H; Shafaroodi H; Nezami BG; Gholipour T; Hajrasouliha AR; Tavakoli S; Nobakht M; Moore KP; Mani AR; Dehpour AR
Br J Pharmacol; 2007 Jul; 151(5):591-601. PubMed ID: 17486141
[TBL] [Abstract][Full Text] [Related]
9. Increased anandamide induced relaxation in mesenteric arteries of cirrhotic rats: role of cannabinoid and vanilloid receptors.
Domenicali M; Ros J; Fernández-Varo G; Cejudo-Martín P; Crespo M; Morales-Ruiz M; Briones AM; Campistol JM; Arroyo V; Vila E; Rodés J; Jiménez W
Gut; 2005 Apr; 54(4):522-7. PubMed ID: 15753538
[TBL] [Abstract][Full Text] [Related]
10. Acute hypertension reveals depressor and vasodilator effects of cannabinoids in conscious rats.
Ho WS; Gardiner SM
Br J Pharmacol; 2009 Jan; 156(1):94-104. PubMed ID: 19133994
[TBL] [Abstract][Full Text] [Related]
11. Effects of chronic nitric oxide synthase inhibition on the cardiovascular responses to cannabinoids in vivo and in vitro.
Wheal AJ; Bennett T; Randall MD; Gardiner SM
Br J Pharmacol; 2007 Mar; 150(5):662-71. PubMed ID: 17245361
[TBL] [Abstract][Full Text] [Related]
12. VR1-mediated depressor effects during high-salt intake: role of anandamide.
Wang Y; Kaminski NE; Wang DH
Hypertension; 2005 Oct; 46(4):986-91. PubMed ID: 16144988
[TBL] [Abstract][Full Text] [Related]
13. Cannabinoid receptor 2 agonist ameliorates mesenteric angiogenesis and portosystemic collaterals in cirrhotic rats.
Huang HC; Wang SS; Hsin IF; Chang CC; Lee FY; Lin HC; Chuang CL; Lee JY; Hsieh HG; Lee SD
Hepatology; 2012 Jul; 56(1):248-58. PubMed ID: 22290687
[TBL] [Abstract][Full Text] [Related]
14. Systemic and portal hemodynamic effects of anandamide.
Garcia N; Járai Z; Mirshahi F; Kunos G; Sanyal AJ
Am J Physiol Gastrointest Liver Physiol; 2001 Jan; 280(1):G14-20. PubMed ID: 11123193
[TBL] [Abstract][Full Text] [Related]
15. Endocannabinoids acting at CB1 receptors mediate the cardiac contractile dysfunction in vivo in cirrhotic rats.
Bátkai S; Mukhopadhyay P; Harvey-White J; Kechrid R; Pacher P; Kunos G
Am J Physiol Heart Circ Physiol; 2007 Sep; 293(3):H1689-95. PubMed ID: 17557913
[TBL] [Abstract][Full Text] [Related]
16. Endothelium-dependent mechanisms of the vasodilatory effect of the endocannabinoid, anandamide, in the rat pulmonary artery.
Baranowska-Kuczko M; MacLean MR; Kozłowska H; Malinowska B
Pharmacol Res; 2012 Sep; 66(3):251-9. PubMed ID: 22627170
[TBL] [Abstract][Full Text] [Related]
17. Hypotensive effect of anandamide through the activation of CB1 and VR1 spinal receptors in urethane-anesthetized rats.
del Carmen García M; Adler-Graschinsky E; Celuch SM
Naunyn Schmiedebergs Arch Pharmacol; 2003 Oct; 368(4):270-6. PubMed ID: 14504685
[TBL] [Abstract][Full Text] [Related]
18. Pharmacological characterization of receptor types mediating the dilator action of anandamide on blood vessels of the rat knee joint.
Lam FF; Luk PW; Ng ES
Life Sci; 2007 Mar; 80(16):1495-502. PubMed ID: 17275857
[TBL] [Abstract][Full Text] [Related]
19. Anandamide is able to inhibit trigeminal neurons using an in vivo model of trigeminovascular-mediated nociception.
Akerman S; Kaube H; Goadsby PJ
J Pharmacol Exp Ther; 2004 Apr; 309(1):56-63. PubMed ID: 14718591
[TBL] [Abstract][Full Text] [Related]
20. Human brain endothelium: coexpression and function of vanilloid and endocannabinoid receptors.
Golech SA; McCarron RM; Chen Y; Bembry J; Lenz F; Mechoulam R; Shohami E; Spatz M
Brain Res Mol Brain Res; 2004 Dec; 132(1):87-92. PubMed ID: 15548432
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]